A Single Base Difference between Pit-1 Binding Sites at the hGH Promoter and Locus Control Region Specifies Distinct Pit-1 Conformations and Functions

ABSTRACT Activation of the human growth hormone (hGH-N) gene in pituitary somatotropes is mediated by a locus control region (LCR). This LCR is composed of DNase I-hypersensitive sites (HS) located −14.5 kb to −32 kb relative to the hGH-N promoter. HSI, at −14.5 kb, is the dominant determinant of hGH-N expression and is essential for establishment of a 32-kb domain of histone acetylation that encompasses the active hGH locus. This activity is conferred by three binding sites for the POU domain transcription factor Pit-1. These Pit-1 elements are sufficient to activate hGH-N expression in the mouse pituitary. In contrast, Pit-1 sites at the hGH-N promoter are consistently unable to mediate similar activity. In the present study, we demonstrate that the functional difference between the promoter-proximal and the HSI Pit-1 binding sites can be attributed in part to a single base difference. This base affects the conformation of the Pit-1/DNA complex, and reciprocal exchange of the divergent bases between the two sets of Pit-1 elements results in a partial reversal of their transgenic activities. These data support a model in which the Pit-1 binding sites in the hGH LCR allosterically program the bound Pit-1 complex for chromatin activating functions.

[1]  S. Asa,et al.  Pit-1 Binding Sites at the Somatotrope-specific DNase I Hypersensitive Sites I, II of the Human Growth Hormone Locus Control Region Are Essential for in Vivo hGH-N Gene Activation* , 1999, The Journal of Biological Chemistry.

[2]  J. K. Oeser,et al.  Accessory Elements, Flanking DNA Sequence, and Promoter Context Play Key Roles in Determining the Efficacy of Insulin and Phorbol Ester Signaling through the Malic Enzyme and Collagenase-1 AP-1 Motifs* , 2002, The Journal of Biological Chemistry.

[3]  T. Richmond,et al.  DNA binding-induced conformational change of the yeast transcriptional activator PRTF , 1990, Cell.

[4]  S. Liebhaber,et al.  The human growth hormone gene is regulated by a multicomponent locus control region , 1995, Molecular and cellular biology.

[5]  S. Liebhaber,et al.  The Human Growth Hormone Gene Cluster Locus Control Region Supports Position-independent Pituitary- and Placenta-specific Expression in the Transgenic Mouse* , 2000, The Journal of Biological Chemistry.

[6]  B. Luisi,et al.  The virtuoso of versatility: POU proteins that flex to fit. , 2000, Journal of molecular biology.

[7]  Larry W. Swanson,et al.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 , 1990, Nature.

[8]  A phorbol ester-insensitive AP-1 motif mediates the stimulatory effect of insulin on rat malic enzyme gene transcription. , 1998, Molecular endocrinology.

[9]  M. Rosenfeld,et al.  Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. , 1994, The Journal of biological chemistry.

[10]  Matthias Wilmanns,et al.  Synergism with the Coactivator OBF-1 (OCA-B, BOB-1) Is Mediated by a Specific POU Dimer Configuration , 2000, Cell.

[11]  S. Liebhaber,et al.  Specification of unique Pit-1 activity in the hGH locus control region , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Cohen,et al.  Defective retinoic acid regulation of the Pit-1 gene enhancer: a novel mechanism of combined pituitary hormone deficiency. , 1999 .

[13]  M. Rosenfeld,et al.  Mutation of the POU-Specific Domain of Pit-1 and Hypopituitarism Without Pituitary Hypoplasia , 1992, Science.

[14]  M. Rosenfeld,et al.  POU domain family values: flexibility, partnerships, and developmental codes. , 1997, Genes & development.

[15]  M. Karin,et al.  GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. , 1993, Genes & development.

[16]  M. Rosenfeld,et al.  Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. , 2000, Science.

[17]  David Baltimore,et al.  One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.

[18]  L. Cohen,et al.  A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  M. Karin,et al.  Function of the homeodomain protein GHF1 in pituitary cell proliferation. , 1991, Science.

[20]  F. Wondisford,et al.  A Mutation in the POU-Homeodomain of Pit-1 Responsible for Combined Pituitary Hormone Deficiency , 1992, Science.

[21]  G L Gilliland,et al.  The three-dimensional structure of a glutathione S-transferase from the mu gene class. Structural analysis of the binary complex of isoenzyme 3-3 and glutathione at 2.2-A resolution. , 1992, Biochemistry.

[22]  M. Rosenfeld,et al.  The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1—Pit-1 interactions , 1990, Cell.

[23]  C. Glass,et al.  Signal-specific co-activator domain requirements for Pit-1 activation , 1998, Nature.

[24]  S. Liebhaber,et al.  A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. , 2002, Molecular cell.

[25]  L. Cohen,et al.  CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression. , 1999, The Journal of clinical investigation.

[26]  Juli D. Klemm,et al.  Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules , 1994, Cell.

[27]  S. Asa,et al.  DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Rosenfeld,et al.  Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. , 1997, Genes & development.

[29]  L W Swanson,et al.  Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. , 1990, Genes & development.

[30]  M. Rosenfeld,et al.  A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. , 1989, Genes & development.

[31]  K. Struhl,et al.  Methylation and Uracil Interference Assays for Analysis of Protein‐DNA Interactions , 1996, Current protocols in molecular biology.

[32]  M Wilmanns,et al.  Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. , 2001, Molecular cell.

[33]  M. Karin,et al.  Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues , 1990, Nature.

[34]  M. Rosenfeld,et al.  Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements , 1990, Nature.

[35]  S. Liebhaber,et al.  Targeted Recruitment of Histone Acetyltransferase Activity to a Locus Control Region* , 2000, The Journal of Biological Chemistry.

[36]  S. Rhodes,et al.  A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. , 1993, Genes & development.

[37]  M. Parker,et al.  Crystallization of glutathione S-transferase from human placenta. , 1990, Journal of molecular biology.

[38]  M. Rosenfeld,et al.  A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype , 1988, Cell.

[39]  W. Schaffner,et al.  Identification of a novel lymphoid specific octamer binding protein (OTF‐2B) by proteolytic clipping bandshift assay (PCBA). , 1988, The EMBO journal.